Common Stock Alternative Reporting
OTC Pink Limited Information
Verified Company Profile 11/14/2016
Contact Info
  • 3250 Bloor St.W
  • Suite 600
  • Toronto, ONT M8X 2X9
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Jun 30, 2016 Quarterly Report
CIK 0001103309
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2012
Employees 4 a/o Sep 24, 2013
Company Officers/Contacts
Daniel Bagi, M.D. President, CEO, IR
Company Directors
Daniel Bagi, M.D.
Company Notes
  • Formerly=CGI Communications Services, Inc. until 7-2008
Service Providers
Accounting/Auditing Firm
KLJ & Associates, LLP
1660 Highway 100 South
Suite 100
St. Louis Park, MN, 55416
United States

Legal Counsel
Szaferman Lakind Blumstein & Blader, PC
101 Grovers Mill Road
2nd Floor
Lawrenceville, NJ, 08648
United States

Investor Relations Firm
Not Available
AXXE Security Details
Share Structure
Market Value1 $80,265 a/o Dec 07, 2016
Authorized Shares 1,000,000,000 a/o May 24, 2016
Outstanding Shares 802,649,390 a/o Aug 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Corporate Stock Transfer, Inc.
Shareholders of Record Not Available
Short Selling Data
Short Interest 1,996 (2,001.05%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security